Textron Inc.
NYSE:TXTAerospace & Defense
-$1.05 today
- Market cap
- $14.02B
- Beta
- 0.91
- P/E (TTM)
- 17.5
- EPS (TTM)
- $5.30
- Dividend yield
- 0.09%
Volume 2.60M
Average 1.35M
TXT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Textron Inc.NYSE: TXT
Research & Development · Q2 FY2027 · quarter ended Jun 2026
Research & development declines year over year
Q2 FY2027 research & development of $116M fell 15.3% year over year, ahead of the -104.3% change in trailing-twelve-month research & development. Sequentially, it fell 3.3% from the prior quarter. Over 3 fiscal years it compounded at -4.6% a year.
Context
- Research & development amounted to 3.5% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -15.3% holds above the trailing-twelve-month pace of -104.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 521M USD
- Year-over-year change
- +6.1%
- 4-year CAGR
- -4.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-03 | 521M | +6.1% |
| FY2025 | 2024-12-28 | 491M | -13.9% |
| FY2024 | 2023-12-30 | 570M | -5.2% |
| FY2023 | 2022-12-31 | 601M | -2.9% |
| FY2022 | 2022-01-01 | 619M | — |
Research & Development vs competitors
How TXT compares with its peers on the latest reported figures
- TXT's LTM Jun 2026 research & development of -$33M is the lowest of the 8 companies compared; the peer median is $665M.
- Its year-over-year change of -104.3% is the lowest of 7, against a peer median of -0.3%.
- Research & development amounts to 0.2% of revenue for TXT, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.69B | -1.6% | +8.2% | 3.9% | |
| LTM Sep 2026 | $2.85B | +1.0% | +1.2% | 3.0% | |
| LTM Sep 2026 | $1.81B | +19.0% | +25.0% | 3.4% | |
| LTM Sep 2026 | $665M | — | +5.6% | 0.8% | |
| LTM Oct 2026 | $486M | -14.0% | +0.4% | 0.9% | |
| LTM Jul 2026 | $438M | +80.2% | -3.9% | 1.9% | |
| LTM Sep 2026 | $0 | -100.0% | -2.9% | 0.0% | |
| LTM Jun 2026 | -$33M | -104.3% | -4.6% | 0.2% | |
| Peer median (excluding TXT) | $665M | -0.3% | +1.2% | 1.9% | |
Competitors are the stored peer set for TXT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Dec 2022 | FY2024 Dec 2023 | FY2025 Dec 2024 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 12.38B | 12.87B | 13.68B | 13.7B | 14.8B |
| Cost of Revenue | 10.3B | 10.2B | 10.84B | 11.2B | 12.1B |
| Gross Profit | 2.09B | 2.67B | 2.85B | 2.5B | 2.7B |
| Gross Margin | 16.8% | 20.7% | 20.8% | 18.3% | 18.2% |
| Research & Development | 619M | 601M | 570M | 491M | 521M |
| Selling, General & Admin | 1.22B | 1.19B | 1.23B | 1.16B | 1.17B |
| Operating Expenses | 1.22B | 1.79B | 1.8B | 1.65B | 1.69B |
| Depreciation & Amortization | 390M | 397M | 395M | 382M | 401M |
| EBITDA | 1.41B | 1.52B | 1.56B | 1.42B | 1.66B |
| EBITDA Margin | 11.3% | 11.8% | 11.4% | 10.4% | 11.2% |
| Operating Income | 864M | 883M | 1.05B | 855M | 1B |
| Operating Margin | 7.0% | 6.9% | 7.7% | 6.2% | 6.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 142M | 107M | 77M | 97M | 126M |
| Other Income / Expenses | 9M | 133M | 34M | 88M | 136M |
| Income Before Tax | 873M | 1.02B | 1.09B | 943M | 1.14B |
| Pre-Tax Margin | 7.1% | 7.9% | 7.9% | 6.9% | 7.7% |
| Income Tax Expense | 126M | 154M | 165M | 118M | 214M |
| Net Income | 746M | 861M | 921M | 824M | 921M |
| Net Margin | 6.0% | 6.7% | 6.7% | 6.0% | 6.2% |
| EPS (Basic) | 3.33 | 4.05 | 4.62 | 4.38 | 5.12 |
| EPS (Diluted) | 3.30 | 4.01 | 4.56 | 4.33 | 5.11 |
| Weighted Avg Shares | 216.9M | 212.81M | 201.53M | 189.86M | 179.88M |
| Weighted Avg Shares (Diluted) | 216.9M | 214.97M | 201.77M | 190.31M | 180.26M |
Textron Inc.
NYSE:TXT
Intrinsic Alpha fair value
Locked
Current Price
$82.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.